Changqing Wang

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

Jeffrey J. Molldrem, Peter P. Lee, Changqing Wang et al. · Nature Medicine · 2000 · 669 citations

Life Sciences, Immunology, Oncology +11

Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial

Xinfeng Liu, Qiliang Dai, Ruidong Ye et al. · The Lancet Neurology · 2019 · 638 citations

Medicine, Neurosurgery, Surgery +14

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan et al. · The Lancet Diabetes & Endocrinology · 2017 · 320 citations

Medicine, Cardiology, Pharmacology +16

Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells

Jeffrey J. Molldrem, Peter P. Lee, Shreya Kant et al. · Journal of Clinical Investigation · 2003 · 207 citations · Full text

Life Sciences, Immunology, Oncology +14

Selective impairment of attentional networks of orienting and executive control in schizophrenia

Kai Wang, Jin Fan, Yi Dong et al. · Schizophrenia Research · 2005 · 176 citations

Medicine, Neuroscience, Psychiatry +16